Skin Cancer

Lines of Research

01.Study of the mechanisms involved in the generation of skin cancer with a specific search for new prognostic factors as well as therapeutic approaches
02.Skin cancer prevention with research into the field of sun protection
03.Analysis of the aetiopathology of psoriasis and its treatment by both immunotherapy and phototherapy mechanisms

Sun exposure and protection habits in transplant athletes: an international survey

Navarrete-De Galvez, M; Sanchez, JMR; Navarrete-De Galvez, E; Aguilera, J; Rivas-Ruiz, F; de Troya-Martin, M; Herrera-Ceballos, E; de Galvez, MV – 2022

Sun Protection Behaviour and Sunburns in Spanish Cyclists

Molinero, DD; Paulano, MR; Ruiz, FR; Sanchez, NB; Aranda, MVD; Maqueda, GD; Martin, MD – 2022

Sun Protection Policies and Practices in Preschool and Elementary Schools in Andalusia (Spain)

Garcia-Harana, C; Aranda, MVD; Blazquez-Sanchez, N; Rivas-Ruiz, F; Rodriguez-Martinez, A; de Troya-Martin, M – 2022

Sunscreens effectiveness are not altered by concomitant use of moisturizing creams: An ultraviolet reflectance photography study

de Galvez, MV; Aguilera, J; Leal, M; Sanchez-Roldan, C; Herrera-Ceballos, E – 2022

The potential role of UV and blue light from the sun, artificial lighting, and electronic devices in melanogenesis and oxidative stress

de Galvez, EN; Aguilera, J; Solis, A; de Galvez, MV; de Andres, JR; Herrera-Ceballos, E; Gago-Calderon, A – 2022

The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry

Munera-Campos, M; Vilar-Alejo, J; Rivera, R; Carrascosa, JM; Dauden, E; Herrera-Acosta, E; Sahuquillo-Torralba, A; Gomez-Garcia, FJ; Baniandres-Rodriguez, O; de la Cueva, P; Lopez-Estebaranz, JL; Belinchon, I; Ferran, M; Riera-Monroig, J; Rodriguez, L; Carretero, G; Garcia-Donoso, C; Ballesca, F; Llamas-Velasco, M; Herrera-Ceballos, E; Pujol-Marco, C; Nieto-Benito, LM; Ruiz-Genao, DP; Alsina, M; Descalzo, MA; Garcia-Doval, I – 2022

Analysis and evaluation of the operational characteristics of a new photodynamic therapy device.

Navarrete-de Galvez, E; Aguilera, J; Fonda-Pascual, P; de Galvez, MV; de Andres-Diaz, JR; Vidal-Asensi, S; Herrera-Acosta, E; Gago-Calderon, A – 2022

Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

Chicharro, P; Llamas-Velasco, M; Armesto, S; Herrera-Acosta, E; Vidal, D; Vilarrasa, E; Rivera, R; De la Cueva, P; Martorell-Calatayud, A; Ballesca, F; Belinchon, I; Carretero, G; Rodriguez, L; Romero-Mate, A; Pujol-Montcusi, J; Salgado, L; Sahuquillo-Torralba, A; Coto-Segura, P; Baniandres-Rodriguez, O; Feltes, R; Alsina, M; Dauden, E – 2022

Quality of Life During Treatment for Cervicofacial Non-melanoma Skin Cancer

Garcia-Montero, P; de Galvez-Aranda, MV; Blazquez-Sanchez, N; Rivas-Ruiz, F; Millan-Cayetano, JF; Garcia-Harana, C; Martin, MD – 2022

Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients

Chicharro, P; Llamas-Velasco, M; Armesto, S; Acosta, EH; Vidal, D; Vilarrasa, E; Rivera-Diaz, R; De-la-Cueva, P; Martorell-Calatayud, A; Ballesca, F; Belinchon, I; Carretero, G; Rodriguez, L; Romero-Mate, A; Pujol-Montcusi, J; Salgado, L; Sahuquillo-Torralba, A; Coto-Segura, P; Rodriguez, OB; Feltes, R; Riera-Monroig, J; Dauden, E – 2022

Beach Lifeguards’ Sun Exposure and Sun Protection in Spain

Martin, MD; Sanchez, NB; Harana, CG; Leiva, MCA; Arjona, JA; Ruiz, FR; Aranda, MVD – 2021

Booster Effect of a Natural Extract of Polypodium leucotomos (Fernblock (R)) That Improves the UV Barrier Function and Immune Protection Capability of Sunscreen Formulations

Aguilera, J; Vicente-Manzanares, M; de Galvez, MV; Herrera-Ceballos, E; Rodriguez-Luna, A; Gonzalez, S – 2021

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

Hernandez-Fernandez, CP; Carretero, G; Rivera, R; Ferrandiz, C; Dauden, E; De la Cueva, P; Belinchon, I; Gomez-Garcia, FJ; Herrera-Acosta, E; Ruiz-Genao, DP; Ferran, M; Alsina, M; Baniandres-Rodriguez, O; Sanchez-Carazo, JL; Botella-Estrada, R; Sahuquillo-Torralba, A; Rodriguez, L; Vilar-Alejo, J; Garcia-Donoso, C; Carrascosa, JM; Llamas-Velasco, M; Herrera-Ceballos, E; Lopez-Estebaranz, JL; Pujol-Marco, C; Descalzo, MA; Garcia-Doval, I – 2021

Factors related to the evolution of quality of life in patients with cervicofacial non-melanoma skin cancer

Garcia-Montero, P; de Galvez-Aranda, MV; Blazquez-Sanchez, N; Rivas-Ruiz, F; Millan-Cayetano, JF; Harana, CG; Martin, MD – 2021

Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study,

Julia, A; Martinez-Mateu, SH; Domenech, E; Canete, JD; Ferrandiz, C; Tornero, J; Gisbert, JP; Fernandez-Nebro, A; Dauden, E; Barreiro-de Acosta, M; Perez, C; Queiro, R; Lopez-Longo, FJ; Carazo, JLS; Mendoza, JL; Alperi, M; Montilla, C; Venegas, JJP; Munoz, F; Castaneda, S; Aterido, A; Lasanta, ML; Marsal, S; Fonseca, E; Rodriguez, J; Carreira, P; Garcia, V; Pinto-Tasende, JA; Puig, L; Ricart, E; Blanco, F; Gratacos, J; Blanco, R; Taboada, VM; Fernandez, E; Unamuno, P; Gonzalez, I; Garcia, FG; Sanmarti, R; Gutierrez, A; Olive, A; Estebaranz, JLL; Garcia-Planella, E; Torre-Alonso, JC; Andreu, JL; Ramirez, DM; Fernandez, B; Zamorano, MAA; de la Cueva, P; Mateu, PN; Vela, P; Vanaclocha, F; Coromines, H; Munoz, S; Nolla, JM; Herrera, E; Gonzalez, C; de la Fuente, JLM; Vera, M; Erra, A; Roig, D; Zea, A; Comas, ME; Tomas, C; Zarco, P; Pego, JM; Saro, C; Gonzalez, A; Freire, M; Garcia, A; Diez, E; Salvador, G; Diaz, C; Sanchez, S; Dominguez, AW; Mosquera, JA; Ramirez, J; Almaraz, ER; Palau, N; Tortosa, R; Lopez, M; Pluma, A; Aterido, A – 2021

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

Dauden, E; de Lima, GPG; Armesto, S; Herrera-Acosta, E; Vidal, D; Villarasa, E; Rivera, R; de la Cueva, P; Martorell, A; Ballesca, F; Belinchon, I; Carretero, G; Rodriguez, L; Romero-Mate, A; Pujol-Montcusi, J; Salgado, L; Sahuquillo-Torralba, A; Coto-Segura, P; Baniandres, O; Feltes, R; Alsina, M; Llamas-Velasco, M – 2021

Effect of Nail Thickness on Visible Radiation Transmittance: Implications for New Photodynamic Therapy Technologies in Onychomycosis.

Navarrete-de Galvez, E; Aguilera, J; deGalvez, MV; Fonda-Pascual, P; Herrera-Ceballos, E; Gago-Calderon, A – 2020

Ixekizumab vs ustekinumab for skin clearance in patients with moderate to severe psoriasis after a year of treatment: Real-world practice

Herrera-Acosta, E; Garriga-Martina, GG; Suarez-Perez, JA; Martinez-Garcia, E; Herrera-Ceballos, E – 2020

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

Dauden, E; Carretero, G; Rivera, R; Ferrandiz, C; Llamas-Velasco, M; de la Cueva, P; Belinchon, I; Gomez-Garcia, FJ; Herrera-Acosta, E; Ruiz-Genao, DP; Ferran-Farres, M; Alsina, M; Baniandres-Rodriguez, O; Sanchez-Carazo, JL; Sahuquillo-Torralba, A; Fernandez-Freire, LR; Vilar-Alejo, J; Garciia-Donoso, C; Carrascosa, JM; Herrera-Ceballos, E; Lopez-Estebaranz, JL; Botella-Estrada, R; Segovia-Munoz, E; Descalzo, MA; Garcia-Doval, I – 2020

Quality of Life of Cohabitants of People Living with Acne

Martinez-Garcia, E; Arias-Santiago, S; Herrera-Acosta, E; Affleck, A; Herrera-Ceballos, E; Buendia-Eisman, A – 2020

« Entradas más antiguas

P20-441 Uso en vida real de upadacitinib en pacientes adultos y adolescentes que padecen dermatitis atópica de moderada a grave (AD-VISE)

Estudio prospectivo, multicéntrico y a largo plazo para evaluar la seguridad y la eficacia de Nemolizumab (CD14152) en sujetos con dermatitis atópica de moderada a grave

Estudio observacional transversal para la caracterización del Paciente Adulto con Dermatitis Atópica (DA) moderada a grave y la estimación de la prevalencia de la DA en Unidades de Dermatología del ámbito hospitalario en España. (NIS-AD-2193). Estudio DACAR

Estudio observacional retrospectivo en pacientes con Dermatitis Atópica tratados con baricitinib en España (Estudio DAMA-S)

Estudio observacional prospectivo para evaluar la calidad de vida en pacientes con psoriassis en placa tratados con Enstilar por primera vez. QALIPSO_x000D_ NIS-ENSTILAR-1430

Estudio observacional prospectivo con pacientes adultos en tratamiento con Dupixent para la dermatitis atópica

Estudio observacional para evaluar la eficacia descriptiva en la práctica clínica real en pacientes con psoriasis en placas moderada a grave tratados con brodalumab. Estudio BROACTIVE

Estudio multicéntrico, ambispectivo y observacional, en pacientes con psoriasis en placas de moderada a grave, para evaluar su satisfacción con el tratamiento con tildrakizumab.

Estudio de extensión abierto y multicéntrico para caracterizar la seguridad y la eficacia a largo plazo de BMS-986165 en pacientes con psoriasis en placas de moderada a grave

Ensayo Clínico fase II para evaluar la seguridad y eficacia de dos modelos de piel autóloga creada mediante ingeniería de tejidos en la cirugía reconstructiva del carcinoma basocelular.

Adjustable brodalumab dosage regimen compared with standard brodalumab treatment for 52 weeks in subjects with moderate-to-severe plaque psoriasis and ≥120 kg body weight

A multicenter, Prospective, observational study measuring tildrakizumab benefit in Achieving Therapeutic goals in patients with moderate-to-severe plaque psoriasis and inadequate response to previous biologic treatments in clinical practice in Spain.